||EPS - Basic
||Market Cap (m)
|Software & Computer Services
Emis Share Discussion Threads
Showing 401 to 424 of 425 messages
|So regret buying this seems to be turning into a bit of a howler Just a constant downward trajectory|
|may benefit from troubles at a competitor, system 1?|
|Well spotted ; but he is probably the CEO.|
new poster registered today. Filter!|
|I hear that 10% of the work force is getting cut to boost the share price|
|The majority work very hard and are committed to patients - the problems you see headlined are the result of under funding in the face of increasing service demand. Funding needs to be linked to reform but neither party has a great record with nhs reform|
|productivity is dismal both in the hospital service and general practice; some loss of productivity is as a result of all the regulation introduced following Shipman some as a result of a too generous settlement particularly for GPs in 2003 which got them out of providing out of hours cover and for hospital docs who were awarded SPAs supporting professional activities to do much as they wish rather than service work. Absenteeism is rife in the Nursing and ancillary worker ranks. of course Jeremy Corbyn wants to throw more money at it to create a perfect socialist enterprise with all the associated restrictive practices, overmanning, central planning, inefficiency rather than fundamentally reforming...|
|Good company but NHS Trusts are in such financial bad straits they are not making the investments needed to improve productivity and working practices|
|Sorry been out of these awhile but the £10m figure taken from header bar here, however looking at last years full numbers (2015) the profit for the year was £5.3m (so 100 x)
I'm probably working out incorrectly?
|What figures are you using to come up with 50x profits waterloo?
the trading statment says "overall performance for the year was in line with the Board's expectations" forecasts for 2016 were EPS 48.66p rising to 51.38p for 2017. As the board has stated in line with expectations that would give a historic PE of less than 17 at a current price of 820.5 to buy. Cash position has also increased year on year "At its year end, the Group's net debt was GBP0.4m (2015: GBP9.1m), having acquired Intrelate Limited, provider of mobile social care software, for net cash consideration of GBP0.8m on 23 December 2016." The market must have been expecting better, or maybe its the CEO leaving which has caused the sell off.
|diabetic eye screening ought to be an easy business to manage despite the 3m plus patients who need annual retinal screening; I suspect the service is overwhelmed and it is difficult to fit all the patients in but all of this should have been known when EMIS bid for the contracts,|
EMIS battles headwinds in NHS IT market
Healthcare software and services provider EMIS describes an “increasingly difficult environment” in the UK market in today’s trading update. Although EMIS’ overall performance for the year to the end of December was in line with the Board’s expectations, it’s clear that the severe pressures on NHS funds and a pause in procurement whilst the NHS’ Sustainability and Transformation Plans (STPs) were published have made it tough going. EMIS’ share price dipped some 6% on the news in early trading to c887p.
We’ll need to wait for the full results in March to see the figures, but the headlines suggest that in Primary Care, EMIS’ heartland, it is maintaining market share and in Community, Children’s and Mental Health it is gaining market share. Secondary Care was most affected by the pressures on NHS funds but it performed largely in line with expectations thanks to the measures taken in the first half of 2016 (see here).
In contrast, Specialist Care has been impacted by “operational inefficiencies”; and “additional costs associated with the implementation of its new contracts”, such that EMIS is considering a non-cash impairment charge to reflect the delay in contribution created by those additional costs. This is the division that offers image management and storage for the ophthalmology market, which requires rather a different business model to the software sales that EMIS is accustomed to. EMIS is focused on improving the profit profile of these new contracts but there’s clearly a risk that this move away from its software ‘knitting̵7; becomes an unwelcome and unprofitable distraction for the group.
Whatever happens with Specialist Care, 2017 is set to be a busy, and we suspect challenging, year for EMIS. Q1 will see EMIS reorganise internally to bring primary, community and secondary care under common leadership, mirroring the NHS’ need to deliver more integrated care. And it’s continuing its search for a successor to CEO Chris Spencer who announced in December that he intends to retire by the end of the year (see here). ‘HeadwindsR17; will also remain a feature of the NHS IT market, but EMIS says it is confident of overcoming these and delivering a positive performance in 2017.|
|It is very well entrenched, the issue is justifying the value at 50x profits, when it's facing headwinds. (IMO)
I note that there is considerable short interest in EMIS|
|Reaction seems a bit severe
The update didn't contain anything that wasn't known
Emis are in an extremely strong position with big barriers|
|Hit stop this morning. Disappointing as was in my SIPP but it does appear that in the short term this is hitting NHS headwinds. Will look to try and pick up some lower down|
|Trading update on Thursday
|Trading update due this week?|
|Another good end to the week as it just breaches 950p. There has been a lot of volatility here in the share price for no major reason beyond market sentiment I feel.|
|That is a good end to the week , hard to imagine very much has changed in the fundamental business in the last 2 weeks despite a 12% share price rise. I wonder which sellers were flushed out by that drop?|
|Chart looking better now. above 20sma and approaching 50sma|
|accumulated again today.
free stock charts from uk.advfn.com|
|Have decided to dip a toe here.|